|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1901 to 2000 out of 2074 for Cx3cr1

0.03s
Type Details Score
Strain
Attribute String: coisogenic, endonuclease-mediated mutation, mutant strain
Publication
First Author: Fujita M
Year: 2014
Journal: PLoS One
Title: The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site.
Volume: 9
Issue: 5
Pages: e96372
Strain
Attribute String: coisogenic, mutant strain, endonuclease-mediated mutation
Allele
Name: C-X3-C motif chemokine receptor 1; endonuclease-mediated mutation 1, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Null/knockout, Recombinase
Allele
Name: C-X3-C motif chemokine receptor 1; endonuclease-mediated mutation 3, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Null/knockout
Allele
Name: C-X3-C motif chemokine receptor 1; endonuclease-mediated mutation 5, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Null/knockout
Strain
Attribute String: coisogenic, mutant strain, endonuclease-mediated mutation
Strain
Attribute String: coisogenic, mutant strain, endonuclease-mediated mutation
Allele
Name: C-X3-C motif chemokine receptor 1; endonuclease-mediated mutation 4, Cyagen Biosciences
Allele Type: Endonuclease-mediated
Attribute String: Recombinase
Allele
Name: C-X3-C motif chemokine receptor 1; targeted mutation 1.1, Dhavalkumar D Patel
Allele Type: Targeted
Attribute String: Humanized sequence, Inserted expressed sequence, Reporter
Strain
Attribute String: coisogenic, endonuclease-mediated mutation, mutant strain
Allele
Name: transgene insertion MW126, GENSAT Project at Rockefeller University
Allele Type: Transgenic
Attribute String: Recombinase
Allele
Name: C-X3-C motif chemokine receptor 1; targeted mutation 2.1, Steffen Jung
Allele Type: Targeted
Attribute String: Inducible, Recombinase
Allele
Name: C-X3-C motif chemokine receptor 1; endonuclease-mediated mutation 1, Marie Burns
Allele Type: Endonuclease-mediated
Attribute String: Null/knockout, Reporter
Publication
First Author: Krishnacoumar B
Year: 2024
Journal: Bone Res
Title: Caspase-8 promotes scramblase-mediated phosphatidylserine exposure and fusion of osteoclast precursors.
Volume: 12
Issue: 1
Pages: 40
Strain
Attribute String: transgenic, mutant stock
Strain
Attribute String: congenic, mutant strain, targeted mutation
Strain
Attribute String: congenic, mutant strain, targeted mutation
Strain
Attribute String: targeted mutation, mutant strain, congenic
Strain
Attribute String: targeted mutation, mutant strain, congenic
Strain
Attribute String: coisogenic, endonuclease-mediated mutation, mutant strain
Publication  
First Author: Saika F
Year: 2021
Journal: Cells
Title: Chemogenetic Activation of CX3CR1-Expressing Spinal Microglia Using Gq-DREADD Elicits Mechanical Allodynia in Male Mice.
Volume: 10
Issue: 4
HT Experiment
Series Id: E-GEOD-66211
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
Publication  
First Author: Saika F
Year: 2020
Journal: Front Pharmacol
Title: Chemogenetic Regulation of CX3CR1-Expressing Microglia Using Gi-DREADD Exerts Sex-Dependent Anti-Allodynic Effects in Mouse Models of Neuropathic Pain.
Volume: 11
Pages: 925
Publication  
First Author: Royzman D
Year: 2022
Journal: Front Immunol
Title: The soluble CD83 protein prevents bone destruction by inhibiting the formation of osteoclasts and inducing resolution of inflammation in arthritis.
Volume: 13
Pages: 936995
Publication  
First Author: Peckert-Maier K
Year: 2023
Journal: Front Immunol
Title: CD83 expressed by macrophages is an important immune checkpoint molecule for the resolution of inflammation.
Volume: 14
Pages: 1085742
Publication
First Author: Dorf ME
Year: 2000
Journal: J Neuroimmunol
Title: Astrocytes express functional chemokine receptors.
Volume: 111
Issue: 1-2
Pages: 109-21
Publication  
First Author: Yang H
Year: 2024
Journal: Int J Mol Sci
Title: Adoptive Transfer of CX3CR1-Transduced Tregs Homing to the Forebrain in Lipopolysaccharide-Induced Neuroinflammation and 3xTg Alzheimer's Disease Models.
Volume: 25
Issue: 24
Publication
First Author: Zhao XF
Year: 2020
Journal: J Neurosci
Title: Microglial mTOR is Neuronal Protective and Antiepileptogenic in the Pilocarpine Model of Temporal Lobe Epilepsy.
Volume: 40
Issue: 40
Pages: 7593-7608
Genotype
Symbol: Cx3cr1/Cx3cr1<+> Gt(ROSA)26Sor/Gt(ROSA)26Sor<+>
Background: involves: 129P2/OlaHsd * 129X1/SvJ
Zygosity: cn
Has Mutant Allele: true
Publication
First Author: Eisa NH
Year: 2023
Journal: iScience
Title: Enniatin A inhibits the chaperone Hsp90 and unleashes the immune system against triple-negative breast cancer.
Volume: 26
Issue: 12
Pages: 108308
Publication
First Author: Okuma A
Year: 2017
Journal: Nat Commun
Title: p16Ink4a and p21Cip1/Waf1 promote tumour growth by enhancing myeloid-derived suppressor cells chemotaxis.
Volume: 8
Issue: 1
Pages: 2050
Publication  
First Author: Zhang B
Year: 2024
Journal: J Clin Invest
Title: Interruption of KLF5 acetylation promotes PTEN-deficient prostate cancer progression by reprogramming cancer-associated fibroblasts.
Volume: 134
Issue: 14
Publication
First Author: de Almeida MMA
Year: 2023
Journal: Stem Cell Reports
Title: Fractalkine enhances oligodendrocyte regeneration and remyelination in a demyelination mouse model.
Volume: 18
Issue: 2
Pages: 519-533
Publication  
First Author: Heir R
Year: 2024
Journal: J Neurosci
Title: Astrocytes Are the Source of TNF Mediating Homeostatic Synaptic Plasticity.
Volume: 44
Issue: 14
Publication  
First Author: Alam MM
Year: 2021
Journal: eNeuro
Title: Deficiency of Microglial Autophagy Increases the Density of Oligodendrocytes and Susceptibility to Severe Forms of Seizures.
Volume: 8
Issue: 1
Publication  
First Author: Madalena KM
Year: 2022
Journal: Exp Neurol
Title: Genetic deletion of the glucocorticoid receptor in Cx(3)cr1(+) myeloid cells is neuroprotective and improves motor recovery after spinal cord injury.
Volume: 355
Pages: 114114
Genotype
Symbol: Cx3cr1/Cx3cr1<+> Gt(ROSA)26Sor/Gt(ROSA)26Sor<+>
Background: involves: 129P2/OlaHsd * C57BL/6
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Cx3cr1/Cx3cr1<+> Gt(ROSA)26Sor/Gt(ROSA)26Sor<+>
Background: involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Cx3cr1/Cx3cr1<+> Gt(ROSA)26Sor/Gt(ROSA)26Sor<+>
Background: involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6NCrl
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Cx3cr1/Cx3cr1<+> Gt(ROSA)26Sor/Gt(ROSA)26Sor<+>
Background: involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6NCrl
Zygosity: cn
Has Mutant Allele: true
Publication
First Author: Palomino DC
Year: 2015
Journal: Einstein (Sao Paulo)
Title: Chemokines and immunity.
Volume: 13
Issue: 3
Pages: 469-73
Protein Domain
Type: Family
Description: The chemokine family is divided into four classes based on the number and spacing of their conserved cysteines: 2 Cys residues may be adjacent (the CC family), or separated by an intervening residue (the CXC family), or have only one of the first two Cys residues (C chemokines), or contain both cysteines separated by three intervening residues (CX3C chemokines).This entry includes beta-chemokines (CC chemokines), in addition to gamma (C chemokines) and delta-chemokines (CX3C chemokines). CC chemokines stimulate mainly monocytes, but also basophils, eosinophils, T-lymphocytes, and natural killer (NK) cells. C-C motif chemokine 2 (CCL2) stimulates chemotaxis of monocytes and several cellular events associated with chemotaxis. Two other chemokines structurally related to CCL2 are CCL8 (MCP-2) and CCL7 (MCP-3) [].The C chemokine subfamily is composed of two members, XC chemokine ligand 1 (XCL1), also known as lymphotactin or SCM-1 alpha, and XC chemokine ligand 2 (XCL2), also known as SCM-1 beta []. The cognate receptor for these chemokines is XCR1 []. The only CX3C chemokine identified to date is CX3C chemokine ligand 1 (CX3CL1), also known as fractalkine or neurotactin. With its unique CX3CR1 receptor [], it is involved in adherence to the endothelium of the inflammatory monocyte population [].
Publication
First Author: Ancuta P
Year: 2003
Journal: J Exp Med
Title: Fractalkine preferentially mediates arrest and migration of CD16+ monocytes.
Volume: 197
Issue: 12
Pages: 1701-7
Publication
First Author: Imai T
Year: 1997
Journal: Cell
Title: Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion.
Volume: 91
Issue: 4
Pages: 521-30
Publication
First Author: Wang Y
Year: 2010
Journal: J Clin Invest
Title: TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice.
Volume: 120
Issue: 2
Pages: 422-32
Publication
First Author: Westmuckett AD
Year: 2009
Journal: Arterioscler Thromb Vasc Biol
Title: Lack of tyrosylprotein sulfotransferase activity in hematopoietic cells drastically attenuates atherosclerosis in Ldlr-/- mice.
Volume: 29
Issue: 11
Pages: 1730-6
Publication
First Author: Tian Y
Year: 2016
Journal: J Immunol
Title: A Context-Dependent Role for IL-21 in Modulating the Differentiation, Distribution, and Abundance of Effector and Memory CD8 T Cell Subsets.
Volume: 196
Issue: 5
Pages: 2153-66
Publication
First Author: Royer DJ
Year: 2018
Journal: Invest Ophthalmol Vis Sci
Title: Corneal Epithelial Cells Exhibit Myeloid Characteristics and Present Antigen via MHC Class II.
Volume: 59
Issue: 3
Pages: 1512-1522
Publication
First Author: Gomez-Nicola D
Year: 2010
Journal: Exp Neurol
Title: Aggravated experimental autoimmune encephalomyelitis in IL-15 knockout mice.
Volume: 222
Issue: 2
Pages: 235-42
Publication  
First Author: Hamers AA
Year: 2016
Journal: BMC Genomics
Title: Nur77-deficiency in bone marrow-derived macrophages modulates inflammatory responses, extracellular matrix homeostasis, phagocytosis and tolerance.
Volume: 17
Pages: 162
Publication  
First Author: Sarikidi A
Year: 2022
Journal: Biomedicines
Title: Altered Immunomodulatory Responses in the CX3CL1/CX3CR1 Axis Mediated by hMSCs in an Early In Vitro SOD1(G93A) Model of ALS.
Volume: 10
Issue: 11
Publication
First Author: Bemiller SM
Year: 2018
Journal: J Neuroinflammation
Title: Genetically enhancing the expression of chemokine domain of CX3CL1 fails to prevent tau pathology in mouse models of tauopathy.
Volume: 15
Issue: 1
Pages: 278
Publication  
First Author: Gabbouj S
Year: 2019
Journal: Neurobiol Aging
Title: Intranasal insulin activates Akt2 signaling pathway in the hippocampus of wild-type but not in APP/PS1 Alzheimer model mice.
Volume: 75
Pages: 98-108
Publication
First Author: Chu KL
Year: 2020
Journal: J Leukoc Biol
Title: GITR differentially affects lung effector T cell subpopulations during influenza virus infection.
Volume: 107
Issue: 6
Pages: 953-970
Publication
First Author: Sato Y
Year: 2012
Journal: PLoS One
Title: Effective elicitation of human effector CD8+ T Cells in HLA-B*51:01 transgenic humanized mice after infection with HIV-1.
Volume: 7
Issue: 8
Pages: e42776
Publication
First Author: Khandelwal P
Year: 2013
Journal: PLoS One
Title: Ocular mucosal CD11b+ and CD103+ mouse dendritic cells under normal conditions and in allergic immune responses.
Volume: 8
Issue: 5
Pages: e64193
Publication
First Author: Yu AK
Year: 2015
Journal: Hum Mol Genet
Title: Mitochondrial complex I deficiency leads to inflammation and retinal ganglion cell death in the Ndufs4 mouse.
Volume: 24
Issue: 10
Pages: 2848-60
Publication  
First Author: Cunha C
Year: 2016
Journal: Mediators Inflamm
Title: Exploring New Inflammatory Biomarkers and Pathways during LPS-Induced M1 Polarization.
Volume: 2016
Pages: 6986175
Publication
First Author: Borsig L
Year: 2014
Journal: Oncogene
Title: Inflammatory chemokines and metastasis--tracing the accessory.
Volume: 33
Issue: 25
Pages: 3217-24
Publication
First Author: Koenen A
Year: 2017
Journal: PLoS One
Title: The DRF motif of CXCR6 as chemokine receptor adaptation to adhesion.
Volume: 12
Issue: 3
Pages: e0173486
Publication      
First Author: Godwin MS
Year: 2020
Journal: Am J Physiol Lung Cell Mol Physiol
Title: The chemokine CX3CL1/fractalkine regulates immunopathogenesis during fungal-associated allergic airway inflammation.
Publication  
First Author: Yli-Karjanmaa M
Year: 2019
Journal: Front Neurosci
Title: Topical Administration of a Soluble TNF Inhibitor Reduces Infarct Volume After Focal Cerebral Ischemia in Mice.
Volume: 13
Pages: 781
Publication  
First Author: Barbosa-Silva MC
Year: 2022
Journal: Brain Behav Immun
Title: Mice lacking 5-lipoxygenase display motor deficits associated with cortical and hippocampal synapse abnormalities.
Volume: 100
Pages: 183-193
Publication
First Author: Gayen M
Year: 2022
Journal: J Biol Chem
Title: The CX3CL1 intracellular domain exhibits neuroprotection via insulin receptor/insulin-like growth factor receptor signaling.
Volume: 298
Issue: 11
Pages: 102532
Publication  
First Author: Li Z
Year: 2023
Journal: Dis Model Mech
Title: A kidney resident macrophage subset is a candidate biomarker for renal cystic disease in preclinical models.
Volume: 16
Issue: 1
Publication  
First Author: Tripathi S
Year: 2024
Journal: J Clin Invest
Title: Pediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF fusion pilocytic astrocytoma.
Volume: 134
Issue: 19
Publication
First Author: Mathur R
Year: 2019
Journal: Mucosal Immunol
Title: Induction of autophagy in Cx3cr1+ mononuclear cells limits IL-23/IL-22 axis-mediated intestinal fibrosis.
Volume: 12
Issue: 3
Pages: 612-623
Publication
First Author: Kemp GM
Year: 2022
Journal: Mol Psychiatry
Title: Sustained TNF signaling is required for the synaptic and anxiety-like behavioral response to acute stress.
Volume: 27
Issue: 11
Pages: 4474-4484
Publication
First Author: Lewitus GM
Year: 2016
Journal: Neuron
Title: Microglial TNF-α Suppresses Cocaine-Induced Plasticity and Behavioral Sensitization.
Volume: 90
Issue: 3
Pages: 483-91
Publication
First Author: Pernici CD
Year: 2019
Journal: Sci Rep
Title: Time course images of cellular injury and recovery in murine brain with high-resolution GRIN lens system.
Volume: 9
Issue: 1
Pages: 7946
Publication
First Author: Combadiere C
Year: 1998
Journal: J Biol Chem
Title: Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1.
Volume: 273
Issue: 37
Pages: 23799-804
Publication
First Author: Sbrana S
Year: 2005
Journal: Cytometry B Clin Cytom
Title: Post-reperfusion changes of monocyte function in coronary blood after extracorporeal circulation.
Volume: 65
Issue: 1
Pages: 14-21
Publication
First Author: Raport CJ
Year: 1995
Journal: Gene
Title: The orphan G-protein-coupled receptor-encoding gene V28 is closely related to genes for chemokine receptors and is expressed in lymphoid and neural tissues.
Volume: 163
Issue: 2
Pages: 295-9
Publication
First Author: Ludwig A
Year: 2007
Journal: Thromb Haemost
Title: Transmembrane chemokines: versatile 'special agents' in vascular inflammation.
Volume: 97
Issue: 5
Pages: 694-703
Publication
First Author: Hundhausen C
Year: 2003
Journal: Blood
Title: The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion.
Volume: 102
Issue: 4
Pages: 1186-95
Publication
First Author: Garton KJ
Year: 2001
Journal: J Biol Chem
Title: Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).
Volume: 276
Issue: 41
Pages: 37993-8001
Publication
First Author: Umehara H
Year: 2004
Journal: Arterioscler Thromb Vasc Biol
Title: Fractalkine in vascular biology: from basic research to clinical disease.
Volume: 24
Issue: 1
Pages: 34-40
Protein Domain
Type: Family
Description: Chemokines (chemotactic cytokines) are a family of chemoattractant molecules. They attract leukocytes to areas of inflammation and lesions, and play a key role in leukocyte activation. Originally defined as host defense proteins, chemokines are now known to play a much broader biological role []. They have a wide range of effects in many different cell types beyond the immune system, including, for example, various cells of the central nervous system [], and endothelial cells, where they may act as either angiogenic or angiostatic factors [].The chemokine family is divided into four classes based on the number and spacing of their conserved cysteines: 2 Cys residues may be adjacent (the CC family); separated by an intervening residue (the CXC family); have only one of the first two Cys residues (C chemokines); or contain both cysteines, separated by three intervening residues (CX3C chemokines).Chemokines exert their effects by binding to rhodopsin-like G protein-coupled receptors on the surface of cells. Following interaction with their specific chemokine ligands, chemokine receptors trigger a flux in intracellular calcium ions, which cause a cellular response, including the onset of chemotaxis. There are over fifty distinct chemokines and least 18 human chemokine receptors []. Although the receptors bind only a single class of chemokines, they often bind several members of the same class with high affinity. Chemokine receptors are preferentially expressed on important functional subsets of dendritic cells, monocytes and lymphocytes, including Langerhans cells and T helper cells [, ]. Chemokines and their receptors can also be subclassified into homeostatic leukocyte homing molecules (CXCR4, CXCR5, CCR7, CCR9) versus inflammatory/inducible molecules (CXCR1, CXCR2, CXCR3, CCR1-6, CX3CR1).The only CX3C chemokine identified to date is CX3C chemokine ligand 1 (CX3CL1), also known as fractalkine or neurotactin. It is a transmembrane molecule containing a chemokine domain on an extended mucin-like stalk []. Both the adhesive and chemotactic effects of CX3CL1 are mediated through CX3C chemokine receptor type 1 (CX3CR1), also known as fractalkine receptor []. The receptor is expressed specifically on T cells, natural killer cells and monocytes [, ]. Coupling of the receptor to pertussis toxin-sensitive Gi proteins leads to calcium mobilisation and chemotaxis []. In contrast, adhesion mediated by the receptor is insensitive to pertussis toxin and does not appear to involve calcium mobilisation. CX3CR1 has also been found to act as a weak fusion cofactor for some HIV-1 strains, an interaction that can be potently and specifically blocked by CX3CL1 [].
Protein Domain
Type: Family
Description: The only CX3C chemokine identified to date is CX3C chemokine ligand 1 (CX3CL1), also known as fractalkine or neurotactin. With its unique CX3CR1 receptor [], it is involved in adherence to the endothelium of the inflammatory monocyte population [].CX3CL1 and CXCL16 represent two exceptions among the members of the chemokine family. In addition to their chemokine domain, they possess three other domains: a mucin-like stalk, a transmembrane (TM) domain, and a cytosolic tail [, ]. When interacting with their cognate receptors (CX3CR1 and CXCR6, respectively), these chemokines induce cell-cell adhesion []. CX3CL1 and CXCL16 can also be cleaved by metalloproteinases to yield a soluble form that is chemotactic [, ]. CX3CL1 also binds and activates integrins through its chemokine domain in a CX3CR1-dependent and independent manner, binding to the classical ligand-binding site (RGD-binding site, site 1) or to a second site (site 2) in integrins, respectively [].Chemokines (chemotactic cytokines) are a family of chemoattractant molecules. They attract leukocytes to areas of inflammation and lesions,and play a key role in leukocyte activation. Originally defined as host defense proteins, chemokines are now known to play a much broader biological role []. They have a wide range of effects in many different cell types beyond the immune system, including, for example, various cells of the central nervous system [], and endothelial cells, where they may act as either angiogenic or angiostatic factors [].The chemokine family is divided into four classes based on the number and spacing of their conserved cysteines: 2 Cys residues may be adjacent (the CC family); separated by an intervening residue (the CXC family); have only one of the first two Cys residues (C chemokines); or contain both cysteines, separated by three intervening residues (CX3C chemokines).Chemokines exert their effects by binding to rhodopsin-like G protein-coupled receptors on the surface of cells. Following interaction with their specific chemokine ligands, chemokine receptors trigger a flux in intracellular calcium ions, which cause a cellular response, including the onset of chemotaxis. There are over fifty distinct chemokines and least 18 human chemokine receptors []. Although the receptors bind only a single class of chemokines, they often bind several members of the same class with high affinity. Chemokine receptors are preferentially expressed on important functional subsets of dendritic cells, monocytes and lymphocytes, including Langerhans cells and T helper cells [, ]. Chemokines and their receptors can also be subclassified into homeostatic leukocyte homing molecules (CXCR4, CXCR5, CCR7, CCR9) versus inflammatory/inducible molecules (CXCR1, CXCR2, CXCR3, CCR1-6, CX3CR1).
Publication
First Author: Ebrahimian T
Year: 2015
Journal: Arterioscler Thromb Vasc Biol
Title: Absence of Four-and-a-Half LIM Domain Protein 2 Decreases Atherosclerosis in ApoE-/- Mice.
Volume: 35
Issue: 5
Pages: 1190-7
Publication
First Author: Teupser D
Year: 2004
Journal: Proc Natl Acad Sci U S A
Title: Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root.
Volume: 101
Issue: 51
Pages: 17795-800
Publication
First Author: Schuett J
Year: 2019
Journal: Cell Physiol Biochem
Title: Suppressor of Cytokine Signaling 1 is Involved in Gene Regulation Which Controls the Survival of Ly6Clow Monocytes in Mice.
Volume: 52
Issue: 2
Pages: 336-353
Publication
First Author: Gardner CR
Year: 2012
Journal: Toxicol Appl Pharmacol
Title: Regulation of alternative macrophage activation in the liver following acetaminophen intoxication by stem cell-derived tyrosine kinase.
Volume: 262
Issue: 2
Pages: 139-48
Publication  
First Author: Zhang J
Year: 2018
Journal: Transl Neurodegener
Title: Dynamic changes of CX3CL1/CX3CR1 axis during microglial activation and motor neuron loss in the spinal cord of ALS mouse model.
Volume: 7
Pages: 35
Publication
First Author: Reed JR
Year: 2012
Journal: PLoS One
Title: Fibroblast growth factor receptor 1 activation in mammary tumor cells promotes macrophage recruitment in a CX3CL1-dependent manner.
Volume: 7
Issue: 9
Pages: e45877
Publication
First Author: Kim YG
Year: 2015
Journal: PLoS One
Title: Pathogenic Role of a Proliferation-Inducing Ligand (APRIL) in Murine IgA Nephropathy.
Volume: 10
Issue: 9
Pages: e0137044
Publication
First Author: Song C
Year: 2018
Journal: FASEB J
Title: REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulation.
Volume: 32
Issue: 6
Pages: 3215-3228
Protein
Organism: Mus musculus/domesticus
Length: 395  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 395  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 64  
Fragment?: false
Publication
First Author: Bazan JF
Year: 1997
Journal: Nature
Title: A new class of membrane-bound chemokine with a CX3C motif.
Volume: 385
Issue: 6617
Pages: 640-4
Publication  
First Author: Culemann S
Year: 2023
Journal: J Exp Med
Title: Stunning of neutrophils accounts for the anti-inflammatory effects of clodronate liposomes.
Volume: 220
Issue: 6
Publication
First Author: Crotti A
Year: 2014
Journal: Nat Neurosci
Title: Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors.
Volume: 17
Issue: 4
Pages: 513-21
Publication  
First Author: Rivera PD
Year: 2019
Journal: Brain Behav Immun
Title: Removal of microglial-specific MyD88 signaling alters dentate gyrus doublecortin and enhances opioid addiction-like behaviors.
Volume: 76
Pages: 104-115
Protein
Organism: Mus musculus/domesticus
Length: 144  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 133  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 133  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 133  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 65  
Fragment?: false